Crea una nuova bacheca
ENTERPRISE
Immagini Editorial

Abbott To Sell Generic Drug Unit To Mylan For $5.3 Billion

Employees walk near an Abbott Laboratories sign at the company's headquarters complex in Abbott Park, Illinois, U.S., on Monday, July 14, 2014. Abbott Laboratories said it plans to sell its generic drug business for established markets to Mylan Inc., getting in return a share of the newly combined companies in a deal valued at about $5.3 billion. Photographer: Daniel Acker/Bloomberg via Getty Images
Abbott To Sell Generic Drug Unit To Mylan For $5.3 Billion

DETTAGLI

Restrizioni:
Contatta l'ufficio locale per informazioni su qualsiasi tipo di uso commerciale o promozionale.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Attestazione:
Bloomberg / Collaboratore
N. Editorial:
452152892
Collezione:
Bloomberg
Data di creazione:
14 luglio 2014
Tipo di licenza:
Info sulla liberatoria:
Senza liberatoria. Ulteriori informazioni
Fonte:
Bloomberg
Nome oggetto:
ABBOTT MYLAN